The Death of Professor Richard Scolyer and Its Impact on Brain Cancer Research
理查德·斯科利爾教授逝世及其對腦瘤研究的影響
Introduction
Professor Richard Scolyer, a famous pathologist and former Australian of the Year, has died at the age of 59 after three years of treatment for glioblastoma, a type of brain cancer.
著名病理學家、前澳洲年度人物理查德·斯科利爾教授在治療了三年的膠質母細胞瘤（一種腦瘤）後，於59歲時逝世。
Main Body
Professor Scolyer was well-known for his important work in melanoma research, particularly as a leader at the Melanoma Institute of Australia. Working with Professor Georgina Long, he helped change how advanced melanoma is treated by using combination immunotherapy. This approach significantly increased the five-year survival rate from about 5% to 55%. Because of his expertise in this field, he used similar immunotherapy methods when he was diagnosed with glioblastoma in 2023.
斯科利爾教授以其在黑色素瘤研究中的重要工作而聞名，特別是在澳洲黑色素瘤研究所擔任領導者期間。他與 Georgina Long 教授合作，透過使用組合免疫療法，協助改變了晚期黑色素瘤的治療方式。這種方法將五年生存率從約 5% 顯著提高至 55%。由於他在該領域的專業知識，當他在 2023 年被診斷出患有膠質母細胞瘤時，他也採用了類似的免疫療法。
Since this specific cancer usually has a very poor outlook, Professor Scolyer decided to be the first patient in an experimental treatment plan. He received three immunotherapy drugs and a personalized vaccine before having surgery, which was different from the standard medical process. Although the cancer returned in early 2025, the data from his case led to a new clinical trial in the United States and Australia. This trial aims to find out if using immunotherapy before surgery can improve results for other patients.
由於這種特定的癌症通常預後非常不理想，斯科利爾教授決定成為一項實驗性治療計劃的首位患者。他在手術前接受了三種免疫藥物和一種個人化疫苗，這與標準的醫療流程不同。儘管癌症在 2025 年初復發，但他個案的數據促成了美國和澳洲的一項新臨床試驗。該試驗旨在研究手術前使用免疫療法是否能改善其他患者的結果。
In response to his work, the federal government provided a $5.9 million grant to create the Richard Scolyer Chair in Brain Cancer Research at Chris O'Brien Lifehouse. This project is intended to speed up research and make clinical trials more available. Furthermore, Professor Scolyer showed his commitment to science by publishing his results in the journal Nature Medicine and continuing to advocate for patients until his death.
為了回應他的貢獻，聯邦政府提供了 590 萬澳元的撥款，在 Chris O'Brien Lifehouse 設立「理查德·斯科利爾腦瘤研究講座教授」席位。此項目旨在加速研究並提高臨床試驗的可近性。此外，斯科利爾教授在《自然醫學》期刊發表其結果，並在去世前持續為患者發聲，展現了他對科學的奉獻。
Conclusion
Professor Scolyer has passed away, but he leaves behind a legacy of valuable medical data and increased government funding for brain cancer research.
斯科利爾教授雖然逝世，但他留下了寶貴的醫療數據，並增加了政府對腦瘤研究的資金支持。
Vocabulary Learning
🚀 The 'Power-Up' Shift: From Basic to Professional
As an A2 student, you usually say things like: "He did a lot of work" or "The government gave money." This is correct, but B2 students use precise verbs to show exactly how something happened.
Let's look at the "Professional Upgrades" found in this text:
💎 Upgrade 1: Instead of "Gave" Provided
- A2: The government gave a grant.
- B2: The government provided a grant.
- Why? "Provide" sounds formal and official. Use it when talking about services, money, or information.
💎 Upgrade 2: Instead of "Make faster" Speed up
- A2: This project will make research faster.
- B2: This project is intended to speed up research.
- Why? This is a phrasal verb. B2 speakers use these to sound more natural while remaining precise.
💎 Upgrade 3: Instead of "Help" Advocate for
- A2: He helped patients.
- B2: He continued to advocate for patients.
- Why? To "advocate" means to publicly support a cause. It describes a specific kind of help—speaking up for others.
💡 Pro Tip: The 'Result' Connection
Notice how the author links ideas. An A2 student uses "and" or "so." A B2 student uses phrases like "led to".
"the data from his case led to a new clinical trial"
Instead of saying "He had data so there was a trial," use led to to show a direct cause-and-effect chain. This makes your English sound like a bridge between a student and a professional.